Klorzoxazon Evolan (Chlorzoxazone)

Chlorzoxazone reduces muscle spasm by inhibiting polysynaptic reflexes within the spinal cord. This central action dampens excitatory neural pathways, decreasing the transmission of signals that cause involuntary muscle contraction.

The specific dose of Klorzoxazon Evolan is determined by the prescribing clinician based on the patient’s condition, age, weight, and response to therapy. Dosage instructions are provided on the prescription label.

Safety data for chlorzoxazone in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Chlorzoxazone is a centrally acting skeletal muscle relaxant, similar in effect to drugs like cyclobenzaprine or methocarbamol but differs in its specific mechanism of inhibiting spinal polysynaptic reflexes. Its side‑effect profile and drug‑interaction potential may vary, making it a suitable alternative for patients who cannot tolerate other agents.

Klorzoxazon Evolan tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should follow the prescribing physician’s instructions regarding timing and any dietary considerations.

Serious adverse reactions, though rare, include liver toxicity, severe skin reactions such as Stevens‑Johnson syndrome, blood disorders like agranulocytosis, and anaphylactic reactions. Patients should seek immediate medical attention if they notice signs of liver dysfunction, rash, or unexplained bleeding.

Individuals with known hypersensitivity to chlorzoxazone or any of its excipients should avoid the product. Caution is also advised for patients with severe hepatic impairment, those taking multiple CNS depressants, and pregnant or nursing women unless the benefits outweigh the risks.